What is the best treatment for Parkinson’s disease?

As a neurologist, one of the questions I’m most often asked after someone is diagnosed with Parkinson’s disease is what the best treatment is and whether starting treatment early can slow the condition down.

Parkinson’s disease is a long-term neurological condition that requires ongoing care and regular review. Although there is no single treatment that works for everyone, modern therapies can significantly improve symptoms and help people maintain a good quality of life.

In most cases, treatment involves a combination of medication, physical therapies and lifestyle strategies, tailored to each person’s symptoms, priorities and day-to-day life.

For this reason, when people ask whether there is a single “best” treatment for Parkinson’s disease, the answer is a little more complex.

Is there a “best” treatment for Parkinson’s disease?

There is no single “best” treatment for Parkinson’s disease. Every patient is different, and care should be highly individualised.

Medications such as levodopa and other dopamine-based therapies are very effective at improving motor symptoms and often form the foundation of treatment.

For many people, levodopa remains the most effective medication for improving symptoms such as tremor, stiffness and slowness of movement. It works by replacing dopamine, the chemical in the brain that becomes depleted in Parkinson’s disease.

However, medication is only one part of the overall approach.

Equally, and sometimes even more, important are non-medication strategies, including:

• Regular exercise
• Physiotherapy
• Occupational therapy
• Speech therapy
• Psychological support

The most effective treatment plan is one that is tailored to a person’s symptoms, lifestyle, work and personal goals, and reviewed regularly over time as needs evolve.

When should Parkinson’s treatment start?

Many people ask whether they should start treatment straight away after diagnosis, or whether it is better to In practice, treatment usually begins when symptoms start to interfere with daily life. For example, when tremor, stiffness or slowness of movement begins to affect work, walking, sleep or everyday tasks.

Some people worry that starting medications such as levodopa too early might make them less effective later on. However, there is no strong evidence that delaying levodopa improves long-term outcomes. Instead, treatment decisions are usually guided by how much symptoms are affecting the person’s day-to-day life.

Alongside medication decisions, neurologists also encourage people to manage lifestyle factors proactively. Regular exercise, a balanced diet and staying socially and mentally active can all play an important role in maintaining mobility, wellbeing and overall quality of life.

In clinic, this is usually a shared decision between the patient and the neurologist. Together, they consider factors such as:

• How troublesome the symptoms are
• Whether symptoms affect work or daily activities
• Age and general health
• Personal priorities and lifestyle

The aim is not simply to delay medication, but to help people stay comfortable, active and independent for as long as possible.

Can Parkinson’s disease be cured or slowed down?

Currently, Parkinson’s disease cannot be stopped or cured, even if diagnosed early.

However, early diagnosis does make a meaningful difference. It allows symptoms to be managed more effectively and enables people to adopt lifestyle strategies that support long-term brain and physical health.

While no treatment has yet been proven to stop disease progression, there is strong evidence that starting the right treatment early, as part of a holistic approach, helps people continue living life to the full.

Important elements of this approach include:

• Regular aerobic exercise
• Good sleep
• Optimised medication
• Mental stimulation
• Social engagement

Managing non-motor symptoms such as:

• Anxiety
• Depression
• Sleep disturbance

also plays a key role in maintaining overall function and wellbeing.

Can you live a normal life with Parkinson’s disease?

Yes, absolutely.

Many people with Parkinson’s live active, fulfilling lives for many years after diagnosis.

With modern treatments, specialist care and supportive therapies, many continue to:

• Work
• Exercise
• Travel
• Enjoy family and social activities

Parkinson’s is a long-term condition, but with the right care and regular review, quality of life can remain high.h.

When should Parkinson’s treatment be reviewed or adjusted?

Parkinson’s disease requires ongoing care, much like other long-term conditions such as high blood pressure or diabetes.

Regular follow-up with a neurologist experienced in managing Parkinson’s disease is essential, ideally every four to six months. These reviews allow symptoms to be assessed, treatment adjusted and future needs anticipated.

Effective management works best through a multidisciplinary team (MDT) approach, with the patient placed firmly at the centre of care.

This team may include:

• Physiotherapists
• Parkinson’s nurses
• Occupational therapists
• Speech and language therapists

What is the first thing to do if you think you have Parkinson’s?

If you are concerned that you may have Parkinson’s disease, the first step is to seek assessment from a neurologist, ideally one with expertise in Parkinson’s disease.

Diagnosis is based on careful clinical assessment rather than a single test. Early clarity helps reduce uncertainty, allows appropriate treatment to begin promptly, and enables access to:

• Medication
• Education
• Therapy
• Support services

All of these play an important role in long-term management.

About the author

Dr Kit Wu is an award-winning Consultant Neurologist specialising in movement disorders and general neurology, practising at King’s College Hospital NHS Foundation Trust and The Wellington Hospital. She is a member of the Parkinson’s Disease Centre of Excellence at King’s College Hospital, one of only two centres in the UK recognised for excellence in Parkinson’s care and research. Dr Wu holds a PhD in Neurosciences from Imperial College London and is recognised for her work improving access to healthcare for diverse communities.